HR 5461
Special Diabetes Program Reauthorization Act of 2025
Jurisdiction
US Congress
Session
119th Congress (2025-2026)
Last updated at
Jun 14, 2026, 4:15 AM
Take action
Sign in to record your position, submit testimony, or contact your legislator.
Sign in to take action- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Bill overview
This bill aims to reauthorize and extend funding for the Special Diabetes Program for Type I diabetes. Specifically, it increases the annual funding allocated to the program by $160 million per year for five years, from fiscal year 2026 through 2030. The program provides resources for research, education, and screening related to Type 1 diabetes. This reauthorization ensures continued support for individuals and families affected by this chronic condition.
Sponsors
Official sponsors from legislative records.
Primary sponsor
Cosponsors
Arguments in favor
Reasons to support this legislation.
No arguments in favor have been submitted.
Submit yoursArguments opposed
Reasons to oppose this legislation.
No arguments opposed have been submitted.
Submit yoursRead the latest version inline or switch to a previous version.